Bruker Corporation

BRKR Healthcare Medical Devices

Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024. In the quarter to June 2026, revenue grew 5.15%, EPS fell 920.0%, free cash flow grew 28.6% and total debt fell 25.1%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five.

54.80 1.74 −3.08%
Market cap
$8.6B
P/E
0.0×
Fwd P/E
55.7×
Dividend yield
0.36%
F-score
4/9
Altman Z
2.43
Beneish M
−2.56
Dividend safety
34/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

4 4 3 5
ROE
(1.11%) (1.05%) (1.69%) (5.07%)
ROA
(0.38%) (0.37%) (0.60%) (1.73%)
ROIC
0.96% 1.05% 0.73% (0.47%)
Return on Tangible Assets
(1.30%) (1.34%) (2.48%) (6.16%)
Average Days of Receivables
58.47 57.88 57.28 56.94
Free Cash Flow per Share
(0.07) 0.29 0.34 0.62
Free Cash Flow
(10.60) 43.30 51.30 93.90
Other line items

Show all line items

Columns are period end dates